Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-05-000015
Filing Date
2005-08-09
Accepted
2005-08-09 17:29:06
Documents
5
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q r10q-585.txt 10-Q 102628
2 CEO CERTIFICATION r10q-581.txt EX-31.1 3627
3 CFO CERTIFICATION r10q-582.txt EX-31.2 3622
4 CEO CERTIFICATION r10q-583.txt EX-32.1 1845
5 CFO CERTIFICATION r10q-584.txt EX-32.2 1844
  Complete submission text file 0000318306-05-000015.txt   115406
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 051011143
SIC: 2834 Pharmaceutical Preparations